Since mid-2022, the macro acquisition environment has faced the challenges of inflation and increasing interest rates, among a variety of other headwinds. Global deal flow is down from its 2021 peak. Yet, as this white paper...more
The dental subsector has continued to garner interest from healthcare investors over the past several years, largely because the subsector remains fragmented. This offers numerous opportunities for buyers, particularly...more
The urology subsector recently has garnered increased interest in the healthcare industry, partly due to the aging population and surging demand for urologic care. This growing patient population has driven investment...more
The women’s health market continues to see unprecedented competition for transactions. These trends, along with COVID-19-specific transaction considerations, create interesting dynamics for investors and providers in the...more
The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference focuses on investing in and implementing technology. It is authored by Kayla McCann...more